ITGAM and neoplasm: We observed that in a MC38 tumor model, the majority of CD11b+Ly6Chi cells are CCR2+, in that the baseline level of the CD11b+Ly6Chi population was lower in tumors grown in CCR2−/− mice compared with tumors grown in WT mice (Fig. 1b).